(Q33979061)

30 July 2017

1 reference

title

Treatment of systemic mast cell disorders (English)

1 reference

30 July 2017

0 references

A S Worobec

1

1 reference

30 July 2017

1 June 2000

1 reference

Hematology / Oncology Clinics of North America

30 July 2017

1 reference

30 July 2017

14

1 reference

30 July 2017

3

1 reference

30 July 2017

659-87, vii

1 reference

Cutaneous and ocular side-effects of PUVA photochemotherapy--a 10-year follow-up study

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

The effect of cimetidine and propantheline on the symptoms of a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Disodium cromoglycate in the treatment of systemic mastocytosis involving only bone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

1 reference

7 January 2021

Referred for management of mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Cimetidine in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Intractable ascites in systemic mastocytosis treated by portal diversion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Response of severe systemic mastocytosis to interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-alpha and efficacy of interferon-alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

PUVA-treatment of urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

An approach to immunotherapy using antibody to IgE in mast cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Telangiectasia macularis eruptiva perstans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Mithramycin in the Treatment of Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Hematologic malignancies occurring in patients with urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

An eosinophilic fibrohistiocytic lesion of bone marrow in a patient with Hodgkin's disease. A potential for morphologic confusion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Osteopenia in systemic mastocytosis: natural history and responses to treatment with inhibitors of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A Double-Blind Cross-Over Study of the Effect of Ketotifen in Urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Phototherapy of urticaria pigmentosa: clinical response and changes of cutaneous reactivity, histamine and chemotactic leukotrienes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Interferon treatment of patients with chronic urticaria and mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Mast cell leukaemia: evidence for bone marrow origin of the pathological clone

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Systemic mast cell disease: a review of the literature with special focus on the gastrointestinal manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

lnterferon-α in combination with corticosteroids improves systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Treatment of telangiectasia macularis eruptiva perstans with the 585-nm flashlamp-pumped dye laser

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Rush Hymenoptera venom immunotherapy: successful treatment in a patient with systemic mast cell disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Diffuse cutaneous mastocytosis responding to cyproheptadine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Congenital bullous urticaria pigmentosa. Treatment with concomitant use of H1- and H2-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Treatment of systemic mastocytosis with interferon‐γ: failure after appearance of anti‐IFN‐γ antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Molecular genetics and development of mast cells: implications for molecular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A fatal case of portal hypertension complicating systemic mastocytosis in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Effects of tixocortol pivalate on gastrointestinal disease in systemic mastocytosis: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis. Results of a double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Systemic mastocytosis treated with histamine H1 and H2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Clinical advances in mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Short- and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Mastocytosis. Perioperative considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Shock of unknown origin--think of mastocytosis!

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

1 reference

7 January 2021

Histamine metabolism in mastocytosis patients treated with interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Urticaria pigmentosa. Systemic evaluation and successful treatment with topical steroids.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A case of bone marrow mastocytosis associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Systemic mastocytosis--a case treated with interferon alpha and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

[Bullous mastocytosis in a child]

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Urticaria pigmentosa--response to topical steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Effect of Cimetidine on Gastric Hypersecretion and Diarrhea in Systemic Mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Cromolyn sodium in the management of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A case of POEMS syndrome associated with essential thrombocythaemia and dermal mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Malignant systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Radiation therapy in a case of systemic mastocytosis: evaluation of histamine levels and mucosal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Bone density, bone markers and bone radiological features in mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Radiotherapy of refractory bone pain due to systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Solitary mastocytoma treated with tranilast

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Pediatric mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A double-blind, placebo-controlled, crossover trial of ketotifen versus hydroxyzine in the treatment of pediatric mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Response to interferon alfa-2b in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural, and biochemical investigations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Treatment of urticaria pigmentosa using interferon alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

High-dose ultraviolet A1 (UVA1) phototherapy: does it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Response to cyclosporin and low-dose methylprednisolone in aggressive systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Mastocytosis: new understandings in cutaneous pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Solitary mastocytoma on the palm

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Anaesthetic management of systemic mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Long-term effect of interferon alpha treatment in mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

The mast cell and mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Aspirin and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Cytokine treatment of mast-cell-mediated skin diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Diffuse cutaneous mastocytosis. Treatment with oral psoralen plus UV-A

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

The effect of disodium cromoglycate and ketotifen on the excretion of histamine and N tau-methylimidazole acetic acid in urine of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Classification and diagnosis of mastocytosis: current status

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

The treatment of mastocytosis: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Case report of bone mastocytosis: total hip arthroplasty for osteoarthritis and open reduction for condylar fracture of the knee

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Diffuse erythrodermic cutaneous mastocytosis with bone marrow infiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Fatal anaphylaxis after a yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Osteoporotic vertebral fractures in systemic mastocytosis without skin involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Anaphylactic-Like Syndrome in Systemic Mastocytosis Treated with Alpha-2-Interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Hematologic aspects of mastocytosis: II: management of hematologic disorders in association with systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Mastocytosis: diverse presentations and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Systemic mastocytosis associated with chronic myelomonocytic leukemia: clinical features and response to interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A new c-kit mutation in a case of aggressive mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Shock in an infant with bullous mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

A case of systemic mastocytosis; therapeutic efficacy of ketotifen

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Anti-interferon-gamma antibodies in a patient undergoing interferon-gamma treatment for systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Allogeneic marrow transplantation for myeloproliferative disorders other than chronic myelogenous leukemia: review of forty cases

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

c-kit mutation and osteopetrosis-like osteopathy in a patient with systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Hodgkin's and Castleman's disease in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Telangiectasia macularis eruptiva perstans: a case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Treatment of childhood acute myeloid leukaemia using the BFM-83 protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Immunotherapy and other novel therapies, including biologic response modifiers, apheresis, and dietary modifications.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Photochemotherapy of dominant, diffuse, cutaneous mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Oral disodium cromoglycate in the treatment of systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

High-dose UVA1 for urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Systemic mast cell disease associated with primary ovarian mixed malignant germ cell tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

An unproven technique with potentially fatal outcome: provocation/neutralization in a patient with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Malignant mastocytosis with circulating mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Mast cell leukemia: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Intervention with epinephrine in hypotension associated with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Treatment of bullous mastocytosis with disodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Concurrent acute myeloid leukemia and systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970301-4

7 January 2021

10.1016/S0889-8588(05)70301-4

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10909045